Live Pfizer updates

Live Pfizer news coverage of developments with the latest updates. Stay on top of latest Pfizer news stories and find out what just happened, what is going on with Pfizer. The latest real-time news updates and headlines on Pfizer
America Triumphs One Year After Liberation Day
Red Blood Cell Exchange Proves Vital in Severe Babesiosis
AI Model Predicts Liver Cancer Risk From Routine Data
Pfizer, Valneva Lyme Vaccine Shows Strong Phase 3 Results
TGA Product Information Safety Updates 23 March
Pfizer Urges Shareholders to Reject Tutanota Offer
Talzenna, Xtandi Boost Survival in Metastatic Prostate Cancer
Pfizer's Atirmociclib Shows Promise in Phase 2 Breast Cancer Trial
Genetic Risk Score Enhances Diabetes, Obesity Prediction
Nanostructured Vaccines Bolster Disease Defense
Research Activity Up 15%, Bolstering National Rank
Blood Clot Cause in COVID Vaccinations Uncovered
Daily Multivitamins May Slow Biological Aging: Study
Pfizer's Antibody Shows Promise in Atopic Dermatitis Study
FDA Fully Approves Pfizer's BRAFTOVI for Metastatic CRC
TGA Product Information Safety Updates 25 February
When Does Cortisol Become Real Problem?
Microplastics Found in Prostate Tumors
Booster Jabs Reduce Risks Of Covid Deaths, Study Finds
Research: Booster Jabs Slash COVID-19 Death Risk
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival In Metastatic Colorectal Cancer
TGA Product Information Safety Updates 17 February
Case Report Probes mRNA Vaccines-Cancer Link
Engineered Immune Cells Slash Brain Toxic Proteins
FDA Fast-Tracks HYMPAVZI for Hemophilia & B Treatment
Pfizer Unveils TrumpRx Program to Cut Drug Costs
TrumpRx.gov Launches to Lower Drug Prices
New Guidelines Standardize Post-Surgery Tumor Response
Pfizer's Monthly GLP-1 Shot Yields Strong Weight Loss
Medical AI Models Require Enhanced Context for Clinics
Alliance Foundation Phase III PATINA Study in NEJM
Nanoparticles Target Disease Proteins in Dementia, Cancer
€60m AI Drug Discovery Project Launched
Scholars Tackle Environmental, Energy Challenges
TGA Product Information Safety Updates 15 January
CtDNA Levels Post-Therapy Outshine PCR in Cancer Recurrence
Healthcare Innovator Joins Health Data Research Team
Pfizer's BRAFTOVI Boosts Response in Metastatic CRC
Expert Predicts 2026 Viral Threats
Trachoma Intervention Needs Drop Below 100 Million
Pfizer Stands by 2025 EPS, Unveils 2026 Guidance
Pfizer Announces Q1 2026 Dividend
Research: Cannabis Use Doesn't Hinder Quitting Nicotine Vaping
Researchers Selected To National Academy Of Inventors
AI Model Boosts Early Breast Cancer Risk Assessment
Giredestrant Boosts Survival in Early Breast Cancer Trial
Sacituzumab Govitecan Matches Standard Care in Breast Cancer
Tucatinib Boosts First-Line Therapy in HER2+ Breast Cancer